Abstract:Purpose Dexmedetomidine is often used for longer than its labeled indication of 24 hours, raising concerns for potential withdrawal. Data are limited regarding this syndrome in adult patients. This study aimed to further characterize dexmedetomidine withdrawal in critically ill adult patients after prolonged use. Methods This was an institutional review board–approved, single-center, retrospective chart review conducted at a tertiary academic medical center. Adult intensive care unit (ICU) patients on dexmedetomidine for ≥72 hours in 2019 were screened for inclusion. Exclusion criteria were interruption of dexmedetomidine for >6 hours, indications for dexmedetomidine other than sedation, or patients with neurological or burn injury. The major end point was the incidence of dexmedetomidine withdrawal, defined as meeting ≥2 of the following criteria within 24 hours of discontinuation: newly positive Confusion Assessment Method for ICU, Richmond Agitation Sedation Scale score of ≥+2, hypertension, and tachycardia. Minor end points were incidence of individual withdrawal signs as previously described, additional sedatives or antipsychotics required, dose and duration of dexmedetomidine infusion, length of ventilation, ICU and hospital length of stay, and new onset of the following: fever, vomiting, loose stools/diarrhea, diaphoresis, or seizure. Findings Of the 152 patients included, dexmedetomidine withdrawal occurred in 54 patients (35.5%). Rebound hypertension was the most common withdrawal sign (47 patients [87.0%]). In the withdrawal group, significantly more patients required additional β-blockers (29 [53.7%] vs 10 [10.2%]; P < 0.01), were reinitiated on dexmedetomidine (16 [29.6%] vs 10 [10.2%]; P < 0.01), and required a start or increased dose of clonidine (6 [11.1%] vs 3 [3.1%]; P = 0.04). There was no significant difference in the cumulative dose or duration of dexmedetomidine between the groups. Length of ventilation was longer in the withdrawal group (171 hours [83.7–280.8 hours] vs 159 hours [149.0–335.7 hours]; P < 0.01), but there was no difference in ICU or hospital length of stay. Implications Prolonged use of dexmedetomidine was associated with withdrawal syndrome in 35.5% of patients in our study. Larger trials are needed to confirm the risk factors for dexmedetomidine withdrawal and identify measures to prevent withdrawal.

Delirium induced by dexmedetomidine

Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report

Perioperative dexmedetomidine-induced delirium in a patient with schizophrenia: a case report

Dexmedetomidine for the Treatment of Acute Lung Injury: A Fact or Fiction?

The effect of dexmedetomidine on the incidence of postoperative delirium in critically ill elderly patients

Evaluation of Dexmedetomidine Withdrawal and Management After Prolonged Infusion

Dexmedetomidine potential in attenuating postoperative delirium in elderly patients after total hip joint replacement

Effects of dexmedetomidine on emergence delirium and electroencephalogram during the recovery period in older patients undergoing lower limb orthopedic surgery: A randomized, double-blind, placebo-controlled clinical trial

Effects of low-dose dexmedetomidine on postoperative delirium incidence in the elderly with a history of cerebral stroke：a secondary analysis based on a random clinical trial

Impact Of Dexmedetomidine On The Incidence Of Delirium In Elderly Patients After Cardiac Surgery: A Randomized Controlled Trial

Effect of dexmedetomidine on convalescence quality after general anesthesia and postoperative delirium, and on cognitive function in elderly patients undergoing lower limb surgery

[Sedative Effects of Dexmedetomidine in Post-Operative Elder Patients on Mechanical Ventilation].

Sedative effect of different speed of intravenous infusion of dexmedetomidine detected by Narocotrend index on elderly patients

Dexmedetomidine effect on delirium in elderly patients undergoing general anesthesia

Dexmedetomidine is associated with intraoperative hypotension and may bring poor postoperative outcomes

Influence of Dexmedetomidine on Sedation

Abstract 18979: Calm Before the Storm: Exploring the Risk of Torsades De Pointes With Dexmedetomidine Administration

Effects of different dose of dexmedetomidine on postoperative deliriumin from general anaesthesia undergoing hip-replacement surgery in aged hypertensive patients

Dexmedetomidine Versus Midazolam/Propofol Sedation Reduces Delirium In The Intensive Care Unit: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials

&Lt;p>effect of Perioperative Administration of Dexmedetomidine on Delirium after Cardiac Surgery in Elderly Patients: a Double-Blinded, Multi-Center, Randomized Study</p>

Effects of Age Factors on Sedation Induced by Dexmedetomidine